Concepedia

Thomas Büchner

TB

Statistics

Publications

4

Citations

119

H-Index

4

Active since

1990

Affiliations

University of Münster(Current)

University of Göttingen

Thomas Büchner is an author at University of Münster specializing in pharmacotherapy, oncology, and hematology.

Top concepts

Publications per year

1990–2001

4

Publications

4

The significance of trisomy 8 in <i>de novo</i> acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis

Claudia Schoch, Detlef Haase, Christa Fonatsch et al. · British Journal of Haematology · 1997 · 77 citations · Full text

Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone (FIS-HAM) salvage therapy in highly resistant acute leukemias

Wolfgang Kern, Eberhard Schleyer, Jan Braess et al. · Annals of Hematology · 2001 · 21 citations · Full text

, , +10

Acute myeloid leukemia in adults: is postconsolidation maintenance therapy necessary?

Thomas Büchner, W. Hiddemann, Bernhard Wörmann et al. · PubMed · 2000 · 11 citations

High-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia—preliminary clinical and pharmacological data of a randomized comparison

W. Hiddemann, Eberhard Schleyer, Christa Uhrmeister et al. · Cancer Treatment Reviews · 1990 · 10 citations

, , +9

1–4 of 4